ESAM Antibody, anti-mouse, REAfinity™
Synonyms: Endothelial cell-selective adhesion molecule, ESAM1
RECOMBINANT
Bioz Star90/100 Bioz rating
1 Citation
Clone:
REA722 | 1G8
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
FC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for ESAM Antibody, anti-mouse, REAfinity™

Flow cytometry applications
APC
APC-Vio 770
Biotin
PE
PE-Vio 770
PerCP-Vio 700
Vio Bright FITC
Recommended dilution:
1:50
Remark:
Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-111-277, 130-111-463
Description:
Mouse bEnd.3 cells were stained with Anti-ESAM antibodies or with the corresponding REA Control antibodies (left peak). Flow cytometry was performed using the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence or 4',6-diamidino-2-phenylindole (DAPI) fluorescence, as in the case of tandem conjugates.

Application image
Specifications for ESAM Antibody, anti-mouse, REAfinity™
Overview

Clone REA722 recognizes the mouse endothelial cell-selective adhesion molecule (ESAM) antigen, a 55 kDa molecule, which is also known as a transmembrane tight junction protein composed of a single transmembrane domain and a cytoplasmic domain. By affecting endothelial cell contacts, ESAM is mostly expressed on endothelial cells of various organs such as heart, lung, kidney, and skin, participating in the migration of neutrophils through the vessel wall.

Additional information: Clone REA722 displays negligible binding to Fc receptors.

Alternative names

Endothelial cell-selective adhesion molecule, ESAM1

Detailed product information

Technical specifications

Clone
REA722
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody, human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
mouse
Antigen
ESAM
Molecular mass of antigen [kDa]
39
Distribution of antigen
other, heart, kidney, lung, skin
Entrez Gene ID
RRID
AB_2651690, AB_2651691, AB_2651698, AB_2651692, AB_2651699, AB_2651693, AB_2651689, AB_2651696, AB_2651697, AB_2651688, AB_2651694, AB_2905197, AB_2651695

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for ESAM Antibody, anti-mouse, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support